Home

> External Events >

Driving Safety: Sedating Medication and Opioid Agonist Treatment

Driving Safety: Sedating Medication and Opioid Agonist Treatment

PROVIDER: The University of Sydney Discipline of Addiction Medicine

DATE: Ongoing (online)

COST: Free

SYNOPSIS:

Health professionals caring for patients who receive opioid agonist treatment (OAT) need to be aware of the potential impact of treatments and other factors on driving safety. The Driving Safety: Sedating Medications and Opioid Agonist Treatment course is designed to support health professionals in assessing a patient’s fitness to drive, with a focus on sedating medications and OAT.

By completing this short course, you will meet the following learning objectives:

  • Identify factors that can impact on driving safety and diagnosing risks to driving for patients, including those receiving opioid agonist treatment (OAT).
  • Develop an understanding of short-term fitness to drive and long-term medical fitness to drive, including key assessment considerations.
  • Incorporate knowledge around roles and responsibilities, patient confidentiality, and difficult clinical conversations to effectively manage patients in the context of fitness to drive.
  • Understand the medical standards for licensing and reporting legislation within New South Wales.

CPD:

Member of the RACGP will receive 2 Category 2 Points for the 2017-19 Triennium. Members of ACRRM will receive 1 Core Point for the 2017-19 Triennium.

MORE INFORMATION: 

To register and complete the course visit www.drivingsafety.com.au, or contact us on 02 9515 9811.